Clinical Trials : Lupus Nephritis

Completed

Study Name: An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Date: 2011-01-07
Interventions:

Drug: CNTO 136 Type=exact numb

Completed

Study Name: Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Date: 2014-10-06
Interventions:

Biological: Rituximab Rituxima

Completed

Study Name: Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Date: 2010-03-04
Interventions:

Drug: laquinimod Laquinimod 0.

Completed

Study Name: Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis
Condition: Lupus Nephritis
Date: 2010-09-21
Interventions: Drug: Long-acting tacrolimus (Advagraf, Astellas Pharma) Long-acting tacrolimus (Advagraf, Astellas Phar

Not yet recruiting

Study Name: Iguratimod as Treatment for Refractory Lupus Nephritis
Condition: Lupus Nephritis
Date: 2017-02-11
Interventions: Drug: Iguratimod Iguratimod 25mg twice a day, oral administrated.

Search for Clinical Trial Results

Lupus Nephritis - 34 Studies Found

Status	Study
Completed	Study Name: An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis Condition: Lupus Nephritis Date: 2011-01-07 Interventions: Drug: CNTO 136 Type=exact numb
Completed	Study Name: Rituximab and Belimumab for Lupus Nephritis Condition: Lupus Nephritis Date: 2014-10-06 Interventions: Biological: Rituximab Rituxima
Completed	Study Name: Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis Condition: Lupus Nephritis Date: 2010-03-04 Interventions: Drug: laquinimod Laquinimod 0.
Completed	Study Name: Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis Condition: Lupus Nephritis Date: 2010-09-21 Interventions: Drug: Long-acting tacrolimus (Advagraf, Astellas Pharma) Long-acting tacrolimus (Advagraf, Astellas Phar
Not yet recruiting	Study Name: Iguratimod as Treatment for Refractory Lupus Nephritis Condition: Lupus Nephritis Date: 2017-02-11 Interventions: Drug: Iguratimod Iguratimod 25mg twice a day, oral administrated.